Benzinga | Aug 4, 2021 04:27PM EDT

Flexion Therapeutics Q2 EPS $(0.44) Up From $(0.76) YoY, Sales $28.18M Miss $29.01M Estimate

Flexion Therapeutics (NASDAQ:FLXN) reported quarterly losses of $(0.44) per share. This is a 42.11 percent increase over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $28.18 million which missed the analyst consensus estimate of $29.01 million by 2.88 percent. This is a 82.35 percent increase over sales of $15.45 million the same period last year.